BNN — BRAIN Biotech AG Share News
0.000.00%
Last trade - 00:00- €63.36m
- €63.46m
- €50.22m
Brief: BRAIN H1 Adj EBITDA Improves To EUR -1.7 Mln
Brief: Brain Q1 Adjusted EBITDA Improved By EUR 1.3 Mln To EUR 0.0 Mln
Brief: BRAIN Biotechnology FY Adj. EBITDA Down At EUR -5.4 Mln
Brief: BRAIN FY Adj. EBITDA At EUR -5.4 Mln
Brief: Brain: Manfred Bender Set To Join As Chief Financial Officer (CFO)
Brief: Brain Announces Strategic Research Collaboration With Blucon Biotech GmbH
Brief: Brain 9Mth Adjusted Group EBITDA At EUR -4.1 Mln
Brief: BRAIN Announces Creation Of Solascure Ltd. To Continue Development Of Aurase
Brief: B.R.A.I.N. CFO Frank Goebel Asks For Early Termination Of His Management Board Contract
Brief: Brain AG And Cyplus Develop Disruptive Technologies For Biological Processing Of Precious Metal Ores
Brief: BRAIN H1 Adjusted Group EBIT At EUR -3.6 Mln
Brief: B.R.A.I.N.: Takeover Of Majority Stake In Biocatalysts Ltd. In Concluding Negotiations
Brief: BRAIN Announces Major Milestone Within Dolce Partnership
Brief: B.R.A.I.N. AG Establishes US Subsidiary
Brief: B.R.A.I.N. Q1 Adj EBIT Improves To Minus 1.7 Mln Euros
Brief: BRAIN AG Expands Patent Protection For Unique Taste Cell Technology To Europe
Brief: Brain AG Q1 EBIT Loss Narrows To EUR 1.7 Mln
Brief: Brain AG FY Adj EBIT Loss Narrows To 6.4 Million Euros
Brief: BRAIN Granted Patent Protection For The Development Of Biological Antiperspirants